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ABSTRACT
Free-floating tumor cells located in the blood of cancer patients, known as 
circulating tumor cells (CTCs), have become key targets for studying metastasis. 
However, effective strategies to study the free-floating behavior of tumor cells in vitro 
have been a major barrier limiting the understanding of the functional properties of 
CTCs. Upon extracellular-matrix (ECM) detachment, breast tumor cells form tubulin-
based protrusions known as microtentacles (McTNs) that play a role in the aggregation 
and re-attachment of tumor cells to increase their metastatic efficiency. In this study, 
we have designed a strategy to spatially immobilize ECM-detached tumor cells while 
maintaining their free-floating character. We use polyelectrolyte multilayers deposited 
on microfluidic substrates to prevent tumor cell adhesion and the addition of lipid 
moieties to tether tumor cells to these surfaces through interactions with the cell 
membranes. This coating remains optically clear, allowing capture of high-resolution 
images and videos of McTNs on viable free-floating cells. In addition, we show that 
tethering allows for the real-time analysis of McTN dynamics on individual tumor 
cells and in response to tubulin-targeting drugs. The ability to image detached tumor 
cells can vastly enhance our understanding of CTCs under conditions that better 
recapitulate the microenvironments they encounter during metastasis.
INTRODUCTION
Cancer metastasis occurs when epithelial tumor 
cells travel through non-adherent microenvironments, 
like the bloodstream or lymphatics, to a distant organ. 
The presence of tumor cells in the non-adherent 
microenvironment of the bloodstream, known as 
circulating tumor cells (CTCs), has been detected in 
numerous epithelial cancers including breast, prostate, 
colon, and lung [1]. CTCs are an early indicator of 
clinical spread of disease and their levels correlate with 
decreased patient survival [2, 3]. Based on the increasing 
clinical relevance of CTCs, understanding their molecular 
profile is emerging as a new opportunity to gain insight 
on disease progression and patient prognosis beyond 
enumeration alone. Though progress has been made on 
technologies to enhance the identification and enumeration 
of CTCs [1, 4, 5], major limitations remain in performing 
downstream functional studies due to challenges with 
accurate detection and the low number of CTCs that 
can be retrieved from patient blood (frequency of 
approximately 1 in 100 million cells in the bloodstream) 
[1]. Some of the techniques currently being employed to 
analyze CTCs include fluorescence in situ hybridization, 
sequencing, immunostaining, xenograft transplantation, 
and RNA or protein-based analysis [1, 4, 6, 7]. However, 
these methods do not allow for real-time analysis of CTCs 
in an environment that preserves their free-floating nature.
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Microscopy analysis of CTCs has focused almost 
exclusively on cells adhered to surfaces (glass, plastic, 
extracellular matrix (ECM)) owing to the ease of imaging 
and characterization of cells in these static positions. 
However, the functional and molecular characteristics of 
adherent and non-adherent tumor cells are dramatically 
different [8-11]. Thus a critical knowledge gap exists 
in the understanding of epithelial tumor cells in non-
adherent microenvironments, such as those found in 
blood vessels. Non-adherent breast carcinoma cells, for 
example, produce unique tubulin-based microtentacles 
(McTNs) that promote tumor cell aggregation [12, 13], 
reattachment to endothelial layers [14, 15], and retention 
of CTCs in the lungs of mice [16, 17]. New enabling 
technologies to image tumor cells, McTNs, and other 
features in the absence of ECM attachment could vastly 
improve the understanding of dynamic cell behaviors that 
occur in the non-adherent microenvironments encountered 
by CTCs during metastasis. These tools could also support 
opportunities for selective targeting of drugs to McTNs or 
other structures presented preferentially by CTCs during 
metastatic spread, as well as help address rising concerns 
that chemotherapies meant to reduce tumor growth may 
actually increase metastatic risk [18]. Here, we exploited 
the discovery that McTNs form only when protein-based 
adhesions are absent to create an innovative platform for 
real-time imaging of the dynamic features of live, non-
adherent tumor cells. This approach allows new types 
of information to be collected (e.g., McTN behavior on 
live cells over time) while reducing variables such as 
changes in cell function that occur during adhesion or the 
complexities of imaging cells in suspension that drift or 
are washed away during microfluidic flow.
Biomaterials offer many attractive features – stability, 
biocompatibility, versatile chemistries – for controlling 
cell adhesion. Common approaches include chemically 
functionalizing surfaces, incorporating cell adhesion 
peptides, and micropatterning using polymer-based soft 
lithography or electrospinning techniques. Of particular 
note, several recent studies have exploited biomaterials 
to identify CTCs [19-21] or used microfluidic devices 
to isolate and immobilize CTCs by acoustic separation, 
topography, controlled flow rates, and antibody traps [22-
25]. Polyelectrolyte multilayers (PEMs) are nanoscale, 
polymeric materials assembled by electrostatic or hydrogen 
bonding interactions during a layer-by-layer (LbL) 
deposition process. PEMs can be coated on topographically-
complex surfaces (e.g., colloidal, microfluidic) and offer 
programmable surface functionalities depending on the 
polymers used to assemble films. PEMs have recently 
been employed to capture CTCs through incorporation of 
cytophilic polymers or cell-adhesive proteins that promote 
CTCs adhesion [26-28]. However, new strategies are 
needed to study the dynamics of McTNs and other unique 
metastatic features that form only when CTCs are in non-
adherent environments.
To enable this new ability, we identified three design 
features that would allow prolonged, real-time imaging 
and drug screening of McTNs on live tumor cells in a 
free-floating state: 1) optically-clear coatings to support 
imaging, 2) ability to control microfluidic flow over 
cells and 3) simple, low-energy manufacturing process. 
Past studies have demonstrated the utility of PEMs for 
tuning cell adhesion by varying polymer composition 
or through addition of lipids, RGD sequences, or other 
binding moieties [29-34]. Thus we leveraged PEMs to 
design a platform to immobilize live, detached tumor 
cells on microfluidic devices. We show that assembling 
cytophobic PEM films with cytophilic lipid tethers 
maintains the free-floating properties of tumor cells while 
providing spatial immobilization of cells. When tethered, 
McTNs on live cells can be visualized in real time and 
the dynamics of these structures can be assessed during 
microfluidic flow of drugs that enhance or destabilize 
McTNs. This technology could generate fundamental 
insight into a critical stage of metastasis that has been 
largely understudied due to technical challenges and 
support new approaches to exploit McTNs as biomarkers 
for the metastatic efficiency of tumor cells in diagnosis, 
prognosis, and targeted drug design.
RESULTS
The responses of cancer cells detached from 
ECM (i.e., in a circulating or free-floating stage) are 
highly important in survival, apoptosis, metastasis, 
and even in the expression of stem cell characteristics 
[36, 37]. However, tumor cells in this state are greatly 
understudied due to the technical and clinical challenges 
of continuously imaging cells not adhered to surfaces. 
Maintaining free-floating cell behavior of breast cancer 
cells is particularly critical in promoting McTN formation 
[12]. Thus we used breast tumor cells to first test if 
programming the compositions of PEM coatings would 
allow minimal tumor cell adhesion to maintain the free-
floating characteristics (e.g., McTNs) of these cells (Figure 
1A), before adding a lipid tether in subsequent designs.
PEMs inhibit cell attachment allowing for McTN 
visualization
We formed PEMs from two common polymers, 
poly(methacrylic acid) (PMA) and polyacrylamide (PAAm) 
that have previously been shown to limit cell adhesion of 
numerous cell types [29, 38]. Substrates coated with PEMs 
offered precise control over film thickness and did not limit 
optical transmission, a feature important for pre-clinical 
and clinical imaging (Figure 1B). Since human breast 
tumor cells lines have not yet been tested on PEM-coated 
substrates, we first confirmed that PMA/PAAm multilayers 
could prevent cell adhesion in two NCI breast cancer cell 
lines, MDA-MB-436 and MCF-7. MDA-MB-436 cells 
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seeded on slides coated with cytophobic PEMs maintained 
McTN display (Figure 1C), demonstrating for the first 
time maintenance of free-floating tumor cell behavior by 
using PEMs. We next coated multi-well culture plates or 
microfluidic slides with PEMs and allowed cells to attach 
for 0, 6, and 24 hours. The number of cells remaining after 
washing at each time point was then quantified by image 
analysis and cell proliferation (CellTiter). Imaging revealed 
that PEM-coatings prevented attachment of either cell line 
(Figure 1D, 1E, Supplementary Figure S1A, S1B) for at 
least 24 hours using 1, 4, and 8 PMA/PAAm bilayers. Cell 
proliferation data also indicated that deposition of 4 bilayers 
and 8 PMA/PAAm bilayers showed reduced attachment 
compared with 1 bilayer for both lines (Supplementary 
Figure S2A, S2B). Four bilayer films were prioritized for 
future experiments since these films formed cytophobic 
surfaces that most efficiently decreased cell attachment 
while maintaining McTN activity. Coatings did not impact 
the viability of either cell line, regardless of substrate 
(Supplementary Figures S2C–S2F, S3, S4).
Modification of PEMs with lipid tethers retains 
tumor cells after washing
Although PEM-coated surfaces prevented tumor 
cell attachment and supported free floating behavior, these 
cells were removed during washing with buffer. Thus we 
sought to develop a strategy to maintain McTNs while also 
providing spatial localization during microfluidic flow for 
real-time imaging and drug screening. We hypothesized 
that the addition of a terminal lipid layer that interacts 
with cell membranes would loosely tether cells to the 
surface during microfluidic flow. We tested 1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP) and 1,2-dioleoyl-
sn-glycero-3-phosphocholine (DOPC) as cationic and 
zwitterionic lipids, respectively, owing to the ability of these 
molecules to interact with the PEMs electrostatically (Figure 
2A). Following addition of DOTAP or DOPC, total film 
thickness increased, though individual bilayers were still 
only 20nm and optical clarity remained high (Figure 2B, 2C). 
We next tested if the addition of lipid supported tethering of 
Figure 1: PEMs form a cytophobic layer allowing McTN visualization on microfluidic devices. A. Schematic depicting 
coating of microfluidic slide with PEMs to maintain free-floating behavior of tumor cells. B. PEM coatings increase in thickness (left axis, 
black) with the number of bilayers but maintain optical clarity (right axis, gray). Data (mean ± SEM) correspond to samples in triplicate. 
C. Maximum intensity z-projection of MDA-MB-436 cells on PMA4/PAAm4 surfaces showing McTNs (arrows). Scale bar = 10μm. Percent 
of D. MDA-MB-436 and E. MCF-7 cells (mean ± SEM) remaining on surfaces after washing uncoated slides or slides coated with 1, 4, or 
8 PMA/PAAm bilayers. Data represents mean values of three independent experiments.
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breast tumor cells without inhibiting free-floating features 
such as McTNs. Tumor cells were seeded on microfluidic 
slides coated with (PMA/PAAm)4 without lipids (PEM-
no tether), or with either terminal lipid layer (PEM-DOPC 
tether, PEM-DOTAP tether). During successive wash steps, 
DOTAP retained tumor cells more efficiently compared 
to non-tethered cells seeded on microfluidic slides coated 
with PEM only (Figure 3A, 3B). MCF-7 cells exhibited 
significantly higher overall cell retention with PEM-DOTAP 
compared to PEM only over four washes. MDA-MB-436 
cells showed significant retention of cells with PEM-DOTAP 
for the first wash and continued to tether around 10% of 
cells for subsequent washes. Tethering was dependent on 
lipid composition, as after five washes, DOTAP tethered and 
retained 30% of MCF-7 cells, while DOPC was ineffective 
at tethering cells during successive washing (Figure 3A, 3B 
versus Figure 3C, 3D). Representative images of cells from 
each line tethered on these surfaces are shown in Figure 3E 
and Supplementary Figure S5. Since DOTAP demonstrated 
superior tethering for both types of tumor cells, this lipid was 
prioritized for functional assays.
Lipid tethers preserve McTNs and cell viability
We next determined if lipid tethering with DOTAP 
maintained free-floating tumor cell characteristics. As a 
first indicator, McTN frequency was assessed on PEM and 
PEM-DOTAP surfaces. Blinded McTN counts revealed 
no differences in McTN frequency on PEM-no tether and 
PEM-DOTAP surfaces compared to previously published 
counts on low-attach multi-well plates (Figure 4A). These 
results indicate lipid tethering does not impact the ability 
of MDA-MB-436 cells to assemble McTNs, results 
confirmed by epifluorescence imaging of McTNs on cells 
incubated with each type of PEM or substrate (Figure 4B, 
Supplementary Figure S6A). MCF-7 cells exhibited similar 
results (Figure 4A, Supplementary Figure S6B), though 
these cells assembled McTN at lower frequencies, as 
previously reported [39]. Further, toxicity studies confirmed 
tethering does not impact tumor cell viability (Figure 4C–
4E, Supplementary Figure S6C–S6F). Thus for the first time, 
our approach allows maintenance of free-floating tumor cell 
behavior while spatially fixing the location of tumor cells.
Figure 2: Modification of PEMs with lipid tethers. A. Schematic depicting how lipid-terminated PEMs promote interaction with 
tumor cell membranes. B. Film thickness and C. optical clarity (mean ± SEM) after addition of DOTAP (blue) and DOPC [red]. Lipids 
promote growth of film while maintaining an optically-clear substrate for imaging. Data correspond to the mean of samples prepared in 
triplicate with three measurements per surface.
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Lipid tethers allow for real-time high resolution 
McTN imaging in response to drug treatments
One of the greatest challenges in studying free-floating 
cells is the difficulty in measuring their functional properties 
or behavior in real time. This is especially apparent when 
trying to image free-floating cells over time and in three 
dimensions. Epifluorescence is unable to capture McTNs in 
high resolution (Figure 4B). Confocal microscopy of cells 
labeled with a fluorescent membrane dye improves signal 
to noise and allows McTNs to be imaged with high contrast 
(Figure 5Ai, arrows). However, since McTNs occur on free-
floating cells, the time required to generate a 3-dimensional 
stack of z-slice images for tracing McTN length yields 
significant blurring as free-floating cells drift over a surface 
to which they cannot attach. This limitation was encountered 
when imaging cells exposed to PEM surfaces without lipid 
tethers (Figure 5Aii, arrows). The blurring effect of cell drift 
is even more apparent across a time projection (Figure 5Aiii). 
In contrast, tethered breast tumor cells not only maintained 
McTNs (Figure 5Aiv, arrow), but also eliminated blurring of 
McTNs in z-stacks. This strategy also allowed microtentacle 
Figure 3: DOTAP tethers breast cancer cells. Percent cell retention of A. MDA-MB-436 and B. MCF-7 cells plated on microfluidic 
slides coated with PMA4/PAAm4 bilayers alone or with DOTAP. Percent cell retention of C. MDA-MB-436 and D. MCF-7 cells plated 
on microfluidic slides coated with PMA4/PAAm4 bilayers alone or with DOPC. The remaining cells after each wash was quantified 
with CellProfiler and normalized to the initial cell number. Data represents mean of triplicate independent experiments (mean ± SEM). 
E. Representative images of MDA-MB-436 cells at time 0 and after 3 subsequent washes on PMA4/PAAm4 bilayers with no tether and with 
PEM-DOTAP or PEM-DOPC tethers at 4x magnification. Scale bar = 200μm. *P<0.05 **P<0.01.
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length to be traced efficiently across z-stacks (Figure 5Av, 
arrow) and limited drift of the cell body during time-lapse 
imaging (Figure 5Avi). These phenomena are evident during 
time-lapse movies of drifting tumor cells seeded on PEM-
no tether surfaces, whereas DOTAP tethering caused cells 
to remain fixed in one location while preserving McTN 
dynamics (Supplementary Figure S7A, S7B). It is interesting 
to note that debris is seen moving quickly through the field 
throughout the movie while the cell remains immobile and 
centered (Supplementary Figure S7B).
The major advantage in imaging McTNs over time is 
being able to study their responses to drugs not only by McTN 
frequency, but also McTN dynamics. To demonstrate this 
potential, we recorded three dimensional z-stacks of untreated 
MDA-MB-436 cells, cells treated with the microtubule 
destabilizing agent, colchicine, or the microtubule stabilizing 
agent, paclitaxel. Addition of colchicine decreased McTNs 
while paclitaxel enhanced McTNs (Figure 5B). Over time, 
colchicine shrunk McTNs and increased cell blebbing, 
whereas paclitaxel hyperstabilized McTNs, dramatically 
decreasing their dynamics compared to vehicle control. These 
new trends are clearly observable in high resolution movies 
(Supplementary Figure S7C–S7E) that would be otherwise 
impossible without lipid tethering, since microfluidic flow 
would wash these cells away or drift would cause blurring. 
This strategy also creates new opportunities to study free-
floating cell properties on a per-cell basis. For example, we 
measured time-dependent drug response and discovered that 
treatment with colchicine decreased the mean number of 
McTN per cell from 21.6 ± 7.2 to 1.8 ± 1.5, while paclitaxel 
treatment increased the frequency of these structures to 39.6 
± 7.5 McTNs/cell (Figure 5C).
DISCUSSION
The majority of cancer-related deaths are due 
to the spread of tumor cells through the circulation 
from the primary site to a secondary organ [40]. While 
Figure 4: Lipid tethering retains free-floating characteristics of breast tumor cells and does not affect cell viability. 
A. McTN quantification of MDA-MB-436 and MCF-7 cells suspended on a low-attach plate, microfluidic slides with PEM-no tether, 
and microfluidic slides with PEM-DOTAP tether. Data represents blinded quantification of McTN frequency from three independent 
experiments with 100 cells counted for each (mean ± SEM). B. Representative images of McTNs (arrows) on MDA-MB-436 cells seeded 
on PEM-no tether and PEM-DOTAP tether microfluidic slides at 40x magnification. Scale bar = 10μm. Viability of C. MDA-MB-436 and 
D. MCF-7 cells calculated at 0 and 6 hrs after seeding on microfluidic slides with PEM-DOTAP tether. Data represents mean cell viability 
from three independent experiments (mean ± SEM). E. Representative images show viability of MDA-MB-436 cells tethered by DOTAP 
for 6 hrs. Phase contrast, live (green fluorescence), and dead (red fluorescence) images taken at 4x magnification. Scale bar = 200μm.
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in the circulation, tumor cells are in a non-adherent 
microenvironment that is unlike the conditions in a 
primary tumor or the metastatic site. In these non-adherent 
conditions, tumor cells undergo many biochemical and 
structural changes that affect their sensitivity to therapies 
and their overall metastatic efficiency [15, 41]. Classical 
drug studies and microscopy focus on analyzing tumor 
cells attached to a substrate due to the practical ease of 
analyzing cells under static conditions, but these methods 
do not recapitulate the free-floating environment of CTCs. 
Therefore, we have developed a microfluidic device 
that can anchor tumor cells using a lipid moiety while 
preventing their attachment to a substrate.
In this proof-of-concept study we show that 
tethering is an effective way to retain the free-floating 
behavior of cancer cells and provides new opportunities 
to study their functional properties with high-resolution 
microscopy through spatial localization. This strategy 
offers the ability to coat a variety of surfaces, including 
microfluidics. We show that incorporating a lipid moiety 
on PEMs can passively immobilize tumor cells in a 
manner that preserves McTN formation and does not 
affect cell viability. In this method, no cellular adhesive 
properties are necessary because the interaction of the cell 
membrane with the lipid results in cell tethering. Lipids 
have previously been used to immobilize cells [32, 34]; 
here we have advanced this idea to create a simple system 
for studying McTNs on free-floating tumor cells. This 
approach eliminates the need for solvents, patterning, 
designed topographies, or antibodies used in other recent 
studies aimed at promoting adhesion of CTCs. Further, 
cells can be tethered in complete media and in a short 
Figure 5: Lipid tethering allows for real-time McTN imaging in response to drug treatment and minimizes effects of 
drift. A. McTN (arrows) imaging of MDA-MB-436 cells seeded on microfluidic slides with PEM-no tether (i-iii) and PEM-DOTAP tether 
(iv-vi). Representative 1μm slice (i and iv), maximum z-projection of 5 slices at one time point (ii and v), and maximum t-projection after 
20 frames (iii and vi) are shown at 60x magnification. B. McTN (arrow) imaging of MDA-MB-436 cells seeded on microfluidic slides with 
PEM-DOTAP tether after treatment with 5μM colchicine for 15 mins and 1μg/ml paclitaxel for 120 mins. Maximum intensity z-projections 
of five 1μm slices at one time point are shown at 60x magnification. Complete time-lapse movies are available in Fig. S7. Scale bar = 
10μM. C. Manual quantification of the average number of McTNs per cell (mean ± SEM) in MDA-MB-436 cells treated with colchicine 
and paclitaxel. **P<0.01 ***P<0.001.
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time frame, both enabling real-time study of McTNs 
on individual CTCs. Therefore, using this technique, 
tethering of any cell type can be achieved in a simple and 
rapid manner, making this a robust platform to study free-
floating behaviors across various cell types.
In our studies, each PEM lipid formulation tethered 
cancer cells, but the lipid moiety itself altered cell 
retention, with DOTAP – a cationic lipid – driving the 
best tethering. DOPC – a zwitterionic lipid – contains 
a phosphate group which may cause less favorable 
interactions with cell membranes compared to DOTAP. 
While cells were immobilized on the substrate, they 
remained free-floating owing to the cytophobic nature of 
the initial PEM coating. There was some loss of tethered 
cells as a function of the number of washes, but it is likely 
these interactions can be strengthened by incorporation of 
cross-linkable lipids [32, 34, 42, 43]. We also observed 
a difference in the tethering efficiency as a function of 
cell line, with MCF-7 breast cancer cells exhibiting better 
tethering compared to MDA-MB-436 cells. These changes 
may be due to the differences in membrane composition or 
surface marker expression of each cell line [44].
We demonstrate the utility of tethering for tumor 
cell analysis by assessing the response of McTNs 
to microtubule-targeting drugs. Unlike our previous 
studies, it is now possible to add drugs via microfluidic 
exchange without displacing cells, allowing measurements 
of colchicine-dependent McTN disruption [12] and 
paclitaxel-dependent McTN enhancement [18] to be 
measured with time-lapse imaging for the first time. Our 
discovery that paclitaxel hyperstabilizes McTNs, for 
example, is significant since microtubule stability can 
enhance McTN formation and increase the re-attachment 
efficiency of tumor cells [18]. Mouse models of metastasis 
indicate that this increased McTN formation and tubulin 
stability results in greater lung trapping of tumor cells 
[12, 16, 18]. Therefore, analyzing McTN dynamics and 
their response to drugs has important implications on 
the metastatic ability of tumor cells. These technological 
advances should allow many additional quantitative McTN 
metrics to be accurately measured (length, dynamics, etc.) 
and also improve on qualitative observations that have 
until now not been possible on a live, individual cell basis.
High numbers of CTCs correlate with increased 
metastasis and decreased survival of patients with 
metastatic cancer [2, 3, 45, 46]. However, CTC 
enumeration alone may not be a good marker for 
disease staging and prognosis [45]. Therefore, 
improved biologic characterization of CTCs is 
necessary to better understand their clinical value. 
Numerous new approaches have been designed to 
improve CTC detection and enumeration, but the 
ability to study the functional properties of CTCs 
remains difficult [1]. Ex vivo culture of CTCs in 
non-adherent conditions has provided one method 
to analyze CTCs from patients [6]. This PEM-lipid 
tethering technology may be applied to these culturing 
methods to keep cells from adhering, but offers the 
unique capabilities of rapid single-cell analysis 
through staining and imaging in real-time.
Studying the biology of CTCs has suggested 
important consequences for both metastatic efficiency 
and the sensitivity of these structures to candidate cancer 
drugs. Of note, patterns of drug sensitivities have been 
linked to the genetic mutations present in individual CTC 
samples from breast cancer and lung cancer patients, 
indicating that a change in tumor genotypes during the 
course of treatment can lead to drug resistance [6, 41, 
47]. Our work shows tethering tumor cells allows rapid 
analysis of specific drug responses in real-time. Markers 
of epithelial-to-mesenchymal transition (EMT) are 
also upregulated in CTCs with mesenchymal markers 
specifically enriched in CTC clusters. These clusters have 
increased metastatic capabilities compared with single 
cells alone [7, 48]. Thus our approach can be applied to 
these existing techniques for fundamental CTC studies 
at the single-cell level. Assessing the effects of drugs on 
cell viability, EMT markers, or McTNs could all have 
implications on their metastatic phenotype. Tethering 
would also allow these studies to be conducted in a 
manner that more closely recapitulates the free-floating 
environment found in circulation. Though our study 
focuses on the analysis of tumor cells, this simple and 
rapid tethering technology is translatable to numerous 
other cell types that are encountered in the blood 
stream (e.g., red blood cells, platelets, lymphocytes, 
macrophages) and may function differently in a free-
floating environment. With new technologies, CTCs will 
play an increasing role in informing therapy and disease 
progression of cancer patients. Toward this goal, tethering 
CTCs with PEM-lipid films could serve as a new tool 
to analyze CTC samples to provide better personalized 
treatment decisions for patients.
MATERIALS AND METHODS
Cell lines & materials
MDA-MB-436 and MCF-7 cell lines were 
purchased from ATCC and cultured with Dulbecco’s 
Modified Eagle Medium supplemented with 10% 
fetal bovine serum and 1% penicillin-streptomycin 
solution. Poly(methacrylic acid) (MW 100,000) and 
polyacrylamide (PAAm) (MW 5,000,000-6,000,000) 
were purchased from Polysciences. Poly(allylamine 
hydrochloride) (PAH) (MW ~200,000) was purchased 
from Alfa Aesar. 1,2-dioleoyl-3-trimethylammonium-
propane (chloride salt) (DOTAP) and 1,2-dioleoyl-
sn-glycero-3-phosphocholine (DOPC) were purchased 
from Avanti Polar Lipids. Colchicine was purchased 
from Sigma and paclitaxel was purchased from Enzo 
Life Sciences.
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PEM film deposition and characterization on 
planar substrates
For multilayer film deposition, similar to methods 
previously reported [35], PMA and PAAm were prepared 
as 0.01M solutions using ultrapure water and adjusted 
to pH 3. All polymer solutions were filtered with a 0.45 
μm cellulose nitrate filter prior to use in multilayer film 
assembly. For planar substrates, quartz (Chemglass Life 
Sciences) or silicon (Silicon Inc.) were cut into 5mm x 
25mm substrates using a dicing saw (Model 1006, Micro 
Automation). Cut substrates were cleaned with sequential 
washing with acetone, ethanol, methanol, and deionized 
water then charged using an oxygen plasma Jupiter III 
system (March). These substrates were first immersed in 
the polycationic solution PAH (0.05M) for 15 mins then 
rinsed twice using two separate baths of deionized water at 
pH 3 to remove any excess polymer. This primer layer was 
followed by immersion of the substrates into polyanionic 
PMA (0.01M) for 5 mins followed by rinsing as above. 
The substrates were then immersed in a polycationic 
solution of PAAm (0.01M) for 5 mins and rinsed. For 
additional bilayers, the process was repeated without 
the addition of the primer layer (PAH) until the desired 
number of bilayers was assembled. Lipid formulations 
comprised of 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) or 1,2-dioleoyl-3-trimethylammonium-propane 
(DOTAP) were obtained from Avanti Polar Lipids. 
These lipids were prepared as 0.01M solutions with pH 
3 deionized water and sonicated for 60 mins in a room 
temperature water bath. PEMs with a lipid tether were 
prepared by immersing PEM coated substrates in each 
lipid solution for 5 mins followed by two rinsing steps. 
The final, coated substrates were removed from solution, 
blown dry with compressed, filtered air, and stored at 
room temperature prior to characterization. Film thickness 
and optical clarity after deposition onto silicon and quartz 
substrates were measured using a LSE stokes ellipsometer 
(Gaertner Scientific Corportation) and by measuring light 
transmittance at 600nm using an Evolution 60 UV-visible 
spectrophotometer (Thermo Scientific), respectively.
PEM film deposition on microfluidic slides and 
multi-well plates
Uncoated microfluidic slides (1μ-Slide VI 0.4) 
were obtained from Ibidi and tissue culture treated 96-
well plates were obtained from Corning. To coat the 
microfluidic slides, 120μL of each polyelectrolyte solution 
was added to the microchannels and 75μl of solution 
was added to each well of the multi-well plate. After 
incubation, solution was removed via aspiration and rinsed 
twice for 1 min using 120μL of pH 3 water. Bilayers of 
PMA and PAAm were assembled and terminated with 
either DOPC or DOTAP as described above. Following 
deposition, slides were allowed to air dry for 1 hr at room 
temperature then stored at room temperature.
Attachment image analysis
MDA-MB-436 and MCF-7 breast cancer cells were 
seeded on PEM coated microfluidic slides (50,000 cells/
channel) ranging from 0 to 8 bilayers. An Olympus CKX4 
microscope was used for all experiments to capture images 
at 4x magnification. Three pictures per channel were taken 
after cell seeding for each condition to quantify initial cell 
number (t0). At 6 and 24 hrs, media was removed from 
the channel and the channel was washed once before 
addition of new media. Three images per channel were 
taken for each condition. The area of the image occupied 
with cells (as a percent) was quantified using CellProfiler 
(Broad Institute) and the average from three images was 
calculated. The average percentage for each condition was 
then normalized to the area occupied at t0.
Attachment cell titer
MDA-MB-436 and MCF-7 breast cancer cells were 
seeded on PEM coated 96-well plates (20,000 cells/well) 
ranging from 0 to 8 bilayers. At each time point (1, 3, 6, 
and 24 hrs), media was removed from the well and the 
well was washed once before addition of new media. After 
the 24hr time point an additional wash was done on all 
wells. Cell number was determined using CellTiter reagent 
according to manufacturer’s instructions. Each time point 
was normalized to initial cell number from a reading done 
immediately after cell seeding.
PEM viability
MDA-MB-436 and MCF-7 breast cancer cells were 
seeded on PEM coated microfluidic slides with PMA4/
PAAm4 bilayers (50,000 cells/channel). At 0, 6, and 24 
hrs Live/Dead (Life Technologies) reagent was added 
according to manufacturer’s instructions. Corresponding 
phase contrast, live (calcein-AM) green fluorescence, and 
dead (ethidium homodimer-1) red fluorescence images 
were taken in triplicate at 4x magnification with an 
Olympus CKX41 fluorescence microscope. The number 
of cells in each image was quantified using CellProfiler. 
The percent of live and dead cells were calculated by 
quantifying the number of green fluorescence positive and 
red fluorescence positive cells, respectively, and dividing 
by total number of cells in the phase contrast image. GFP 
and Texas Red filters were used to for imaging. MDA-
MB-436 and MCF-7 breast cancer cells were plated on 
96-well black plates with PMA4/PAAm4 bilayers (20,000 
cells/well). At time 0, 1, 3, 6, and 24 hours Live/Dead 
reagent was added and read on a plate reader according 
to manufacturer’s instructions. Relative fluorescence units 
(RFU) were normalized to time 0.
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Tethering washing
MDA-MB-436 and MCF-7 cells were seeded on 
PMA4/PAAm4 coated microfluidic slides with DOPC or 
DOTAP (50,000 cells/channel). Cells were incubated 
for 1 hr to allow for tethering. To quantify initial cell 
number, three images per channel were taken for each 
condition at time 0. After 1 hr, existing media was gently 
removed from the bottom port of each channel and fresh 
media was added to the top port. Following a wash, three 
images were taken per channel for each condition using 
an Olympus CKX41 microscope at 4x magnification. 
This process was repeated for each wash. The area of the 
image occupied with cells (as a percent) was quantified 
using CellProfiler and the average from three images was 
calculated. The average percentage for each condition was 
then normalized to the area occupied at time 0.
Tethering viability
MDA-MB-436 and MCF-7 cells were seeded on 
PMA4/PAAm4 coated microfluidic slides with DOPC or 
DOTAP (50,000 cells/channel). Cells were incubated 
for 1 hr to allow for tethering. After 1 hr, one wash was 
done where the existing media was gently removed 
from the bottom port of each channel and fresh media 
was added to the top port. This wash was to ensure 
only tethered cells were analyzed. At 0 and 6 hrs after 
washing, Live/Dead reagent was added according to 
manufacturer’s instructions. Corresponding phase 
contrast, live (calcein-AM) green fluorescence, and dead 
(ethidium homodimer-1) red fluorescence images were 
taken in triplicate. The number of cells in each image was 
quantified using CellProfiler. The percent of live and dead 
cells were calculated by quantifying the number of green 
fluorescence positive and red fluorescence positive cells, 
respectively, and dividing by total number of cells in the 
phase contrast image. GFP and Texas Red filters were used 
for imaging.
McTN counting
MDA-MB-436 cells were trypsinized, spun down, 
and resuspended in phenol red-free and serum-free 
DMEM. Cells were seeded on PMA4/PAAm4 coated 
microfluidic slides, PMA4/PAAm4 coated microfluidic 
slides with DOTAP, or a low attach 24-well plate (50,000 
cells/channel). Cells were incubated for 1 hr to allow 
for tethering. After 1 hr, one wash was done where the 
existing media was gently removed from the bottom port 
of each channel and fresh media was added to the top 
port on the DOTAP slides. This wash was to ensure only 
tethered cells were analyzed. After this wash, CellMask 
Orange (Life Technologies) cell membrane dye was 
added to each channel to a final concentration of 1:10,000. 
McTNs were scored blindly in a population of 100 cells/
well as previously described [12]. Representative images 
were taken at 40x magnification with an Olympus CKX41 
fluorescence microscope.
Imaging drift and drug treatments
MDA-MB-436 cells were trypsinized, spun down, 
and resuspended in phenol red-free and serum-free 
DMEM. Cells were seeded on PMA4/PAAm4 coated 
microfluidic slides and PMA4/PAAm4 coated microfluidic 
slides with DOTAP (50,000 cells/channel). Cells were 
incubated for 1 hr to allow for tethering. After 1 hr, one 
wash was done where the existing media was gently 
removed from the bottom port of each channel and fresh 
media was added to top port on the DOTAP slides. This 
wash was to ensure only tethered cells were analyzed. 
After this wash, CellMask orange cell membrane dye was 
added to each channel to a final concentration of 1:10,000. 
Cells were treated with 5μM colchicine for 15 mins and 
1μg/ml paclitaxel for 120 mins. McTN imaging was done 
on an Olympus FV100 confocal laser scanning microscope 
at 60x magnification. Five 1μm slices and 20 frames at a 
10 sec frame rate were taken for at least five image sets 
for each condition. The number of McTNs on each cell 
was manually counted on five cells per condition using the 
maximum intensity z-projection at the last frame.
Statistical analysis
Graphpad Prism (version 6.02) was used to 
determine all statistic comparisons. Student’s t-test and 
one-way ANOVA tests were performed with a Tukey 
multiple comparisons post-test as indicated. A p-value of 
0.05 or less was considered statistically significant.
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